liberDi was founded to meet the market need for an easy-to-use, at-home dialysis system that improves treatment benefits and reduces health care costs. liberDi is developing its automatic peritoneal dialysis (PD) system that promises easy setup. The Company anticipates that the system will allow an increasing number of people requiring dialysis to enjoy the benefits of home treatment. Company founder and CEO is Hezkiah Tsoory, who has more than 22 years of experience in business, operations, and R&D.
The liberDi Mission
liberDi aims to be the leader in the field of portable PD systems, with a groundbreaking treatment option that will significantly improve the quality of life for people with end-stage renal disease (ESRD).
Over 25 years’ experience as a specialist in nephrology and hypertension; Head, Department of Nephrology and Hypertension, Carmel Medical Center, Haifa, Israel; President, Israeli Society of Nephrology and Hypertension; Chairman, Nephrology Technology Committee, Clalit Health System
20 years’ experience in nephrology; specialist in nephrology and internal medicine; Director, Dialysis Unit, Carmel Medical Center, Haifa, Israel
Head of the Institute of Nephrology, Rabin Medical Center (Beilinson & Hasharon hospitals), Petah Tikva, Israel. Extensive clinical and research experience in the field of Nephrology in general, and in Peritoneal Dialysis in particular